Mesa Laboratories (MLAB) Cash from Financing Activities (2010 - 2025)

Mesa Laboratories has disclosed Cash from Financing Activities across 16 years of filings, most recently posting -$9.8 million for Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at -$9.8 million, up 4.88% year-over-year; the trailing twelve-month figure through Dec 2025 was -$42.3 million (down 2.52% YoY), and the FY2025 annual result was -$44.5 million, down 235.55% from the prior year.
• Cash from Financing Activities came in at -$9.8 million for Q4 2025 at Mesa Laboratories, down from -$7.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $61.2 million in Q4 2021 to a low of -$18.6 million in Q3 2022.
• The 5-year median for Cash from Financing Activities is -$8.5 million (2024), against an average of -$978350.0.
• Across the five-year window, Cash from Financing Activities jumped 35689.47% in 2021 and tumbled 1710.19% in 2022, its largest moves.
• Mesa Laboratories' Cash from Financing Activities stood at $61.2 million in 2021, then tumbled by 114.51% to -$8.9 million in 2022, then jumped by 784.99% to $60.8 million in 2023, then tumbled by 116.91% to -$10.3 million in 2024, then advanced by 4.88% to -$9.8 million in 2025.
• The last three Cash from Financing Activities figures came in at -$9.8 million (Q4 2025), -$7.9 million (Q3 2025), and -$8.4 million (Q2 2025), per Business Quant data.